SCHEMBL4579971

SCHEMBL4579971

O=C1NCCN(c2ccnc(NCc3ccccc3F)n2)C1c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
CYP1A2 P05177 1/20 0.42
POLB P06746 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
MAPT P10636 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
IDH1 O75874 6/20 0.41
HDAC1 Q13547 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
LMNA P02545 1/20 0.38
VNN1 O95497 1/20 0.36
TAAR1 Q96RJ0 2/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
CLPP Q16740 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4580658 0.91 IDH1 (0.44) IDH1HDAC1HDAC8HDAC6HTR2A
SCHEMBL4581890 0.87 IDH1 (0.54) IDH1HTR2AHTR2CHTR2BHRH4
SCHEMBL4581479 0.86 IDH1 (0.44) IDH1HDAC1HDAC8HDAC6HTR2A
SCHEMBL4581562 0.86 IDH1 (0.39) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL4580805 0.84 MAPK8 (0.42) POLBIDH1HDAC1HDAC8HDAC6
SCHEMBL4580841 0.84 IDH1 (0.42) IDH1HDAC1HDAC8HDAC6HTR2A
SCHEMBL4582251 0.84 OGA (0.44) KDM4EALDH1A1IDH1HDAC1HDAC8
SCHEMBL4581999 0.83 HRH4 (0.56) IDH1HRH4OGA
SCHEMBL4582884 0.82 HRH4 (0.43) IDH1HDAC1HDAC8HDAC6HTR2A
SCHEMBL4581339 0.82 MAPK1 (0.47) ALDH1A1MAPTIDH1LMNAOGA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7323464-B2 Pyridine and pyrimidine derivatives CELLTECH R&D LIMITED (GB) 2008-01-29 US claimed
US-20050080258-A1 Pyridine and pyrimidine derivatives GENTEX CORPORATION 2005-04-14 US claimed
US-7323464-B2 Pyridine and pyrimidine derivatives CELLTECH R&D LIMITED (GB) 2008-01-29 US disclosed
US-20050080258-A1 Pyridine and pyrimidine derivatives GENTEX CORPORATION 2005-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050080258-A1 Pyridine and pyrimidine derivatives ROR1, MAPK1, IRAK1 KDM4E 1283/4885ALDH1A1 682/4885CYP1A2 1524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.